Biotech

All Articles

ArsenalBio increases $325M, turns away from former lead possession

.Arsenal Biosciences is proceeding up. The tissue therapy firm has actually added on $325 million in...

Lilly- supported fat burning biotech documents IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually f...

Aelis' marijuana use drug flunks period 2b, steering Indivior to re-think $100M alternative

.Aelis Farma's chances of securing a quick, beneficial decision on a $100 million option remittance ...

ProKidney stops stage 3 test certainly not required for cell therapy confirmation

.ProKidney has actually ceased some of a set of phase 3 trials for its tissue therapy for kidney dis...

Vaxcyte rises on 'stunning' 31-valent PCV gain against Pfizer

.Vaxcyte revealed what professionals named "spectacular" phase 1/2 information for its own 31-valent...

Recursion's mind disease trial reveals insufficient evidence of effectiveness

.Recursion has actually stumbled by means of an early exam of its own tech-enabled technique to drug...

Acepodia, Pfizer click with each other for chemistry-based tissue therapy

.Phone it a case of really good chemical make up: Acepodia, a biotech based upon Nobel Champion scie...

Praxis epilepsy medicine minimizes confiscations in stage 2 hearing

.Praxis Precision Medicines has actually scored another midphase win in epilepsy this year, with its...

Three officers surrender as Dyne messages combined records for DMD applicant

.After getting away from a professional hold numerous years back, Dyne Therapeutics has actually sho...

Arrowhead fires off period 3 information in rare metabolic disease ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has actually revealed its own give before a possible showdown with Ionis,...